Leukemogenic risk prediction of the cytostatic treatment.
Raposa
T
T
III. Department of Internal Medicine, Semmelweis University Medical School, Budapest, Hungary.
Varkonyi
J
J
D000367:Age Factors; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D003131:Combined Modality Therapy / Q000009:adverse effects; D006801:Humans; D007938:Leukemia / Q000139:chemically induced*; D009154:Mutation; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D009381:Neoplasms, Radiation-Induced / Q000209:etiology; D012307:Risk Factors; D012854:Sister Chromatid Exchange / Q000187:drug effects
D000970:Antineoplastic Agents